Biomea Fusion Inc
NASDAQ:BMEA
During the last 3 months Biomea Fusion Inc insiders bought 196.7k USD , and have not sold any shares. The stock price has dropped by 4% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/bmea/vs/indx/gspc">open performance analysis).
The last transaction was made on
Dec 11, 2025
by
Erdtmann Rainer M
, who
bought
43k USD
worth of
BMEA shares.
During the last 3 months Biomea Fusion Inc insiders bought 196.7k USD , and have not sold any shares. The stock price has dropped by 4% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/bmea/vs/indx/gspc">open performance analysis).
The last transaction was made on
Dec 11, 2025
by
Erdtmann Rainer M
, who
bought
43k USD
worth of
BMEA shares.
Biomea Fusion Inc
Glance View
Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company is headquartered in Redwood City, California and currently employs 51 full-time employees. The company went IPO on 2021-04-16. The firm is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The firm has built FUSION System discovery platform to advance a pipeline of irreversible small molecule product candidates. The firm's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The firm is developing BMF-219 for the treatment of liquid and solid tumors that are dependent on menin, including leukemias containing the mixed lineage leukemia (MLL) fusion protein. The firm is also advancing other preclinical irreversible programs for the treatment of select cancers.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.